Adinda van de Kerkhove

Adinda Van De Kerkhove currently serves as Bestuurder at Zorggroep Ter Weel since November 2024 and has held the position of Voorzitter Raad van Toezicht at Stichting Lentekind since July 2021. Prior experience includes management roles at ZorgSaam Zorggroep Zeeuws-Vlaanderen, where responsibilities spanned from Manager Zorg Thuis to Clustermanager Kortdurende Zorg en Behandeling from April 2017 to September 2024. In the pharmaceutical sector, Adinda held senior positions at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2011 to March 2017, including VP Head of Portfolio Delivery Operations, and at Centocor from January 2000 to March 2012, serving as Clinical Operations Head Immunology and other leadership roles. Earlier experience includes a senior CRA position at Sanofi. Adinda holds a Master’s degree from the University of Amsterdam and has further education from the Erasmus Centrum voor Zorgbestuur.